Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Revenue:
Product Sales Net	$ 5,353	$ 0
Collaboration and license revenue from related party	106	10,223
Grant revenue	0	130
Total revenue	5,459	10,353
Operating expenses:
Cost of Sales	205	0
Research and development	17,476	23,418
Selling, General and Administrative	26,011	16,262
Total operating expenses	43,692	39,680
Loss from operations	(38,233)	(29,327)
Other expense:
Interest income	222	305
Interest expense	(597)	(689)
Total other expense, net	(375)	(384)
Net loss	$ (38,608)	$ (29,711)
Basic and diluted net loss per common share	$ (0.55)	$ (0.43)
Shares used to compute basic and diluted net loss per common share	70,835	69,608